TrialFrontiers in immunology2025

Neoadjuvant sintilimab and chemotherapy for resectable esophageal squamous cell carcinoma: a phase II clinical trial.

Jincheng Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.